Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TACR1 | P25103 | 2/20 | 0.36 |
| ▸ | SNCA | P37840 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 2/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CCR3 | P51677 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3022341 | 0.92 | ALDH1A1 (0.39) | ALDH1A1LMNASMN1; SMN2HTTL3MBTL1 | |
| SCHEMBL3022044 | 0.87 | LMNA (0.35) | ALDH1A1KDM4EKMT2ALMNAHTT | |
| SCHEMBL3799436 | 0.87 | ALDH1A1 (0.40) | ALDH1A1KDM4EKMT2AMAPTMAPK1 | |
| SCHEMBL3802086 | 0.87 | ALDH1A1 (0.35) | ALDH1A1KMT2AMAPTMAPK1LMNA | |
| SCHEMBL3021663 | 0.84 | ALDH1A1 (0.36) | ALDH1A1KDM4EKMT2AMAPTLMNA | |
| SCHEMBL3802447 | 0.83 | LMNA (0.32) | ALDH1A1KDM4EKMT2AMAPTMAPK1 | |
| SCHEMBL3017464 | 0.83 | HTR6 (0.32) | KMT2ALMNASMN1; SMN2L3MBTL1 | |
| SCHEMBL3027934 | 0.82 | ALDH1A1 (0.41) | ALDH1A1KDM4EKMT2AMAPTMAPK1 | |
| SCHEMBL3021682 | 0.82 | ALDH1A1 (0.34) | ALDH1A1KMT2AMAPTLMNASMN1; SMN2 | |
| SCHEMBL3024891 | 0.81 | TACR1 (0.35) | KMT2ATACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100190794-A1 | Herbicidally Active Composition | BASF SE (DE) | 2010-07-29 | — | — | US | claimed |
| US-20100173777-A1 | Piperazine Compounds Having Herbicidal Action | BASF SE (DE) | 2010-07-08 | — | — | US | claimed |
| EP-2157856-A1 | HERBICIDALLY EFFECTIVE COMPOSITION | Basf Se (DE) | 2010-03-03 | — | — | EP | claimed |
| EP-2054394-B1 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | BASF SE (DE) | 2009-11-18 | — | — | EP | claimed |
| EP-2054394-A2 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | Basf Se (DE) | 2009-05-06 | — | — | EP | claimed |
| WO-2008152074-A1 | HERBICIDALLY EFFECTIVE COMPOSITION | BASF SE (DE) | 2008-12-18 | — | — | WO | claimed |
| WO-2008152072-A2 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | BASF SE (DE) | 2008-12-18 | — | — | WO | claimed |
| US-20100190794-A1 | Herbicidally Active Composition | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
| US-20100173777-A1 | Piperazine Compounds Having Herbicidal Action | BASF SE (DE) | 2010-07-08 | — | — | US | disclosed |
| EP-2157856-A1 | HERBICIDALLY EFFECTIVE COMPOSITION | Basf Se (DE) | 2010-03-03 | — | — | EP | disclosed |
| EP-2054394-B1 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | BASF SE (DE) | 2009-11-18 | — | — | EP | disclosed |
| EP-2054394-A2 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | Basf Se (DE) | 2009-05-06 | — | — | EP | disclosed |
| WO-2008152074-A1 | HERBICIDALLY EFFECTIVE COMPOSITION | BASF SE (DE) | 2008-12-18 | — | — | WO | disclosed |
| WO-2008152072-A2 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | BASF SE (DE) | 2008-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100190794-A1 | Herbicidally Active Composition | ECI1, ACLY, SQOR | ALDH1A1 1128/4885KDM4E 2283/4885KMT2A 2213/4885 |
| US-20100173777-A1 | Piperazine Compounds Having Herbicidal Action | CBR3, CBR1, CNPY2 | ALDH1A1 1174/4885KDM4E 4069/4885KMT2A 3366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.